Literature DB >> 22552195

Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses.

Trong Tuan Dao1, Thai Trung Dang, Phi Hung Nguyen, Eunhee Kim, Phuong Thien Thuong, Won Keun Oh.   

Abstract

The emergence of the H1N1 swine flu pandemic has the possibility to develop the occurrence of disaster- or drug-resistant viruses by additional reassortments in novel influenza A virus. In the course of an anti-influenza screening program for natural products, 10 xanthone derivatives (1-10) were isolated by bioassay-guided fractionation from the EtOAc-soluble extract of Polygala karensium. Compounds 1, 3, 5, 7, and 9 with a hydroxy group at C-1 showed strong inhibitory effects on neuraminidases from various influenza viral strains, H1N1, H9N2, novel H1N1 (WT), and oseltamivir-resistant novel H1N1 (H274Y) expressed in 293T cells. In addition, these compounds reduced the cytopathic effect of H1N1 swine influenza virus in MDCK cells. Our results suggest that xanthones from P. karensium may be useful in the prevention and treatment of disease by influenza viruses.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552195     DOI: 10.1016/j.bmcl.2012.04.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

2.  Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4th Edition of the Chinese National Guidelines for the Initial-Stage Management of COVID-19 via Molecular Docking.

Authors:  Yue Sun; Angela Wei Hong Yang; Andrew Hung; George Binh Lenon
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-24       Impact factor: 2.629

Review 3.  Medicinal plants: Treasure for antiviral drug discovery.

Authors:  Sofi Imtiyaz Ali; Wajid Mohammad Sheikh; Muzafar Ahmad Rather; Venugopalan Venkatesalu; Showkeen Muzamil Bashir; Showkat Ul Nabi
Journal:  Phytother Res       Date:  2021-02-16       Impact factor: 6.388

4.  2,4-Di-bromo-1,3-dihy-droxy-9H-xanthen-9-one.

Authors:  Shi-Wen Huang; Zheng-Min Yang; Fu-Ping Huang; Jiang-Ke Qin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-31

Review 5.  Herbal plants and plant preparations as remedial approach for viral diseases.

Authors:  Rajesh Kumar Ganjhu; Piya Paul Mudgal; Hindol Maity; Deepu Dowarha; Santhosha Devadiga; Snehlata Nag; Govindakarnavar Arunkumar
Journal:  Virusdisease       Date:  2015-09-03

6.  Antiviral Protein of Momordica charantia L. Inhibits Different Subtypes of Influenza A.

Authors:  Viroj Pongthanapisith; Kazuyoshi Ikuta; Pilaipan Puthavathana; Wichet Leelamanit
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-09       Impact factor: 2.629

Review 7.  Antiviral natural products and herbal medicines.

Authors:  Liang-Tzung Lin; Wen-Chan Hsu; Chun-Ching Lin
Journal:  J Tradit Complement Med       Date:  2014-01

8.  Polar Constituents and Biological Activity of the Berry-Like Fruits from Hypericum androsaemum L.

Authors:  Giovanni Caprioli; Alessia Alunno; Daniela Beghelli; Armandodoriano Bianco; Massimo Bramucci; Claudio Frezza; Romilde Iannarelli; Fabrizio Papa; Luana Quassinti; Gianni Sagratini; Bruno Tirillini; Alessandro Venditti; Sauro Vittori; Filippo Maggi
Journal:  Front Plant Sci       Date:  2016-03-01       Impact factor: 5.753

Review 9.  Chemical and Biological Research on Herbal Medicines Rich in Xanthones.

Authors:  Jingya Ruan; Chang Zheng; Yanxia Liu; Lu Qu; Haiyang Yu; Lifeng Han; Yi Zhang; Tao Wang
Journal:  Molecules       Date:  2017-10-11       Impact factor: 4.411

Review 10.  The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases.

Authors:  Pardis Mohammadi Pour; Sajad Fakhri; Sedigheh Asgary; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.